These data are sufficient to support the claims and dosage as provided in Sections 2 and 3. The effects of treatment on yield grade, quality grade, marbling score, and liver abscess incidence were evaluated at slaughter. A decrease in marbling scores was observed. No effect of treatment was seen in yield grade or the incidences of liver abscesses. Therefore, no further studies were required.
Human safety is established by data in the parent application.
Therefore, no further studies were required. Plus for increased rate of weight gain when administered to steers fed in confinement for slaughter. Plus in steers fed in confinement for slaughter. The approval of this change is not expected to have any adverse effect on the safety or effectiveness of this new animal drug. Accordingly, this approval did not require a reevaluation of the safety and effectiveness data in the parent application.